Table 3. Parents’ and medical doctors’ responses to the questionnaire on the administration of
intranasal ketamine and midazolam (table A) and placebo (table B) via a mucosal atomiser device
A
Question
Parents
(n)
Score
(median)
Range
Doctors*/
nurses**
(n)
Score
(median)
Range
Helped
19
10
10 -10
5/3
10
10-10
Level of child’s outlook
19
8.9
7-10
5/3
8
7-9
Level of parents’ outlook
19
9.1
8-10
5/3
9.5
9-10
Level of doctors’ outlook
-
-
5/3
8.5
8-10
Level of child’s tolerance of procedures
19
8.7
7-10
5/3
8.2
7-9
Would recommend to other parents
19
9.3
9-10
-
-
Would recommend to other doctors
-
-
5/3
9.4
9-10
Would like to see MAD used routinely
19
9.8
9-10
5/3
10
10
Made the procedure more acceptable
-
-
-
5/3
10
10
The use of INMK by MAD:
B
Question
Parents
(n)
Score
(median)
Range
Doctors*/
nurses**
(n)
Score
(median)
Range
Helped
19
5
3-7
5/3
3
2-4
Level of child’s outlook
19
5.8
5-7
5/3
3
2-4
Level of parents’ outlook
19
4.9
3-7
5/3
5
3-7
Level of doctors’ outlook
-
-
5/3
4
3-5
Level of child’s tolerance of procedures
19
8.5
7-10
5/3
8
7-9
Would recommend to other parents
19
4
3-6
-
-
Would recommend to other doctors
-
-
5/3
3
1-5
Would like to see MAD used routinely
19
4
3-6
5/3
3
1-5
Made the procedure more acceptable
-
-
-
5/3
3
1-5
The use of intranasal sedation (placebo) by
MAD:
*5 unbiased medical doctors were involved in the painful or diagnostic procedures carried out in the study.
*3 unbiased nurses were involved in the painful or diagnostic procedures carried out in the study.
INKM, intranasal midazolam and ketamine
MAD, mucosal atomiser device.